Skip to content

Medical emergency? What to do

Letrozole tops tamoxifen for early breast cancer

3-RXPublished December 29, 20052 min read

Key points

  • As add-on therapy for breast cancer, letrozole appears to be more effective than tamoxifen in reducing the risk of the disease recurring, new research suggests.
  • In the current analysis of the data, reported in Thursday's New England Journal of Medicine, the researchers focused on the drugs that the women were treated with initially.
  • Treatment with tamoxifen was associated with higher rates of blood clots, endometrial cancer, and vaginal bleeding.
  • Letrozole is in a class of drugs known as aromatase inhibitors.

As add-on therapy for breast cancer, letrozole appears to be more effective than tamoxifen in reducing the risk of the disease recurring, new research suggests.

Dr. Beat Thurlimann, from the Senology Center of Eastern Switzerland in Kantonsspital, and colleagues compared the outcomes of 8010 women who were randomly assigned to one of four treatment regimens for 5 years: letrozole; letrozole followed by tamoxifen; tamoxifen; or tamoxifen followed by letrozole.

In the current analysis of the data, reported in Thursday's New England Journal of Medicine, the researchers focused on the drugs that the women were treated with initially. Therefore, women who received letrozole initially were compared with those who received tamoxifen initially.

During an average follow-up period of just over 2 years, a total of 351 cancer recurrences were noted in the letrozole group, while 428 occurred in the tamoxifen group. Compared with tamoxifen, letrozole cut the risk of recurrent disease by 19 percent, the report indicates.

Treatment with tamoxifen was associated with higher rates of blood clots, endometrial cancer, and vaginal bleeding. On the other hand, letrozole therapy was tied to higher rates of skeletal and heart problems, as well as high cholesterol levels.

The study was supported by Novartis Pharmaceuticals Corp., which markets letrozole as Femara.

Letrozole is in a class of drugs known as aromatase inhibitors. The new findings "validate the results of previous studies showing that aromatase inhibitors were more efficacious than tamoxifen" in postmenopausal women with early-stage breast cancer, Dr. Sandra M. Swain comments in a related editorial.

Swain, from the National Cancer Institute in Bethesda, Maryland, adds that longer follow-up from several ongoing studies is needed "to enable us to offer patients sound advice regarding the benefits and long-term risks of aromatase inhibitors."

SOURCE: New England Journal of Medicine, December 28, 2005.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underBreast Cancer
Cancer

Strong social ties benefit breast cancer patients

Breast cancer patients who have a strong social support system in the first year after diagnosis are less likely to die or have a recurrence of cancer, according to new research from Vanderbilt-Ingram Cancer Center…

3 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.